(R)-1-((Benzyloxy)carbonyl)piperidine-2-carboxylic acid, 95.0%, 10g

[1-({2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}amino)-2-nitroethenyl](methyl)amine, 97.0%, 5g

Tetraethylammonium acetate tetrahydrate, 99.0%, 25g

1-Methyl-1H-pyrrolo[2,3-c]pyridine, 97%, 10g

2-Fluoro-5-hydroxy-4-methylbenzoic acid, 95.0%, 5g

[S(R)]-N-[(R)-[2-(Dicyclohexylphosphanyl)phenyl](4-methoxyphenyl)methyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 100mg

ULTROXA(regR) Poly(2-ethyl-2-oxazoline) Azide Terminated (n=approx. 50)500mg

[(2S,3R)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-3,4-DIHYDRO-2H-CHROMEN-3-YL] 3,4,5-TRIHYDROXYBENZOATE, 95%, 250mg

cis-4-Cyclohexene-1,2-dicarboxylic Acid>98.0%(GC)(T)25g

2-(4-Chloro-3-fluorophenyl)-1,3-dioxolane, 98%, 10g

4-OXO-1,3-PIPERIDINEDICARBOXYLIC ACID 1-BENZYL ESTER 3-METHYL ESTER, 95.0%, 1g

Dodecyltriethoxysilane>95.0%(GC)10mL

1(3H)-Isobenzofuranone, 3-butylidene-4,5-dihydro-, 98%, 5mg